DK0925073T3 - Staphylococcus aureus antigen - Google Patents
Staphylococcus aureus antigenInfo
- Publication number
- DK0925073T3 DK0925073T3 DK97941511T DK97941511T DK0925073T3 DK 0925073 T3 DK0925073 T3 DK 0925073T3 DK 97941511 T DK97941511 T DK 97941511T DK 97941511 T DK97941511 T DK 97941511T DK 0925073 T3 DK0925073 T3 DK 0925073T3
- Authority
- DK
- Denmark
- Prior art keywords
- antigen
- aureus
- type
- strains
- staphylococcus aureus
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56938—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/085—Staphylococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/964—Chemistry: molecular biology and microbiology including enzyme-ligand conjugate production, e.g. reducing rate of nonproductive linkage
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/712,438 US5770208A (en) | 1996-09-11 | 1996-09-11 | Staphylococcus aureus B-linked hexosamine antigen |
PCT/US1997/016045 WO1998010788A1 (en) | 1996-09-11 | 1997-09-11 | Staphylococcus aureus antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0925073T3 true DK0925073T3 (da) | 2009-01-19 |
Family
ID=24862114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97941511T DK0925073T3 (da) | 1996-09-11 | 1997-09-11 | Staphylococcus aureus antigen |
Country Status (12)
Country | Link |
---|---|
US (2) | US5770208A (da) |
EP (1) | EP0925073B1 (da) |
JP (2) | JP4282765B2 (da) |
AT (1) | ATE414532T1 (da) |
AU (1) | AU725181B2 (da) |
CA (1) | CA2265498C (da) |
DE (1) | DE69739120D1 (da) |
DK (1) | DK0925073T3 (da) |
ES (1) | ES2317655T3 (da) |
NZ (1) | NZ334828A (da) |
PT (1) | PT925073E (da) |
WO (1) | WO1998010788A1 (da) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7279162B1 (en) | 1990-10-22 | 2007-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection |
US6040137A (en) * | 1995-04-27 | 2000-03-21 | Tripep Ab | Antigen/antibody specification exchanger |
US6660842B1 (en) | 1994-04-28 | 2003-12-09 | Tripep Ab | Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen |
US6933366B2 (en) * | 1996-12-27 | 2005-08-23 | Tripep Ab | Specificity exchangers that redirect antibodies to bacterial adhesion receptors |
US6294177B1 (en) * | 1996-09-11 | 2001-09-25 | Nabi | Staphylococcus aureus antigen-containing whole cell vaccine |
US5770208A (en) * | 1996-09-11 | 1998-06-23 | Nabi | Staphylococcus aureus B-linked hexosamine antigen |
US6610293B1 (en) | 1997-06-16 | 2003-08-26 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine | Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
US7250494B2 (en) * | 1998-06-15 | 2007-07-31 | Biosynexus Incorporated | Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria |
US8142780B2 (en) * | 1998-08-20 | 2012-03-27 | Strox Biopharmaceuticals, Llc | Anti-bacterial antibodies |
US6322788B1 (en) | 1998-08-20 | 2001-11-27 | Stanley Arthur Kim | Anti-bacterial antibodies and methods of use |
US6824997B1 (en) | 1998-09-18 | 2004-11-30 | Binax, Inc. | Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
US9134303B1 (en) | 1998-08-25 | 2015-09-15 | Alere Scarborough, Inc. | ICT immunoassay for Legionella pneumophila serogroup 1 antigen employing affinity purified antibodies thereto |
US6692739B1 (en) * | 1998-08-31 | 2004-02-17 | Inhibitex, Inc. | Staphylococcal immunotherapeutics via donor selection and donor stimulation |
DE69940371D1 (de) * | 1998-09-14 | 2009-03-19 | Nabi Biopharmaceuticals Rockvi | Beta-glucan enthaltende zusammenstellungen und spezifische immunoglobuline |
US7030101B2 (en) | 1998-09-14 | 2006-04-18 | Nabi Biopharmaceuticals | Compositions of β-glucans and specific antibodies |
US6936258B1 (en) * | 1999-03-19 | 2005-08-30 | Nabi Biopharmaceuticals | Staphylococcus antigen and vaccine |
US20030113350A1 (en) | 2001-09-19 | 2003-06-19 | Fattom Ali I. | Glycoconjugate vaccines for use in immune-compromised populations |
ATE419005T1 (de) * | 2001-12-11 | 2009-01-15 | Merck & Co Inc | Staphylococcus aureus exopolysaccharid und verfahren |
US6984381B2 (en) * | 2002-07-05 | 2006-01-10 | The United States Of America As Represented By The Secretary Of Agriculture | Vaccine for the prevention of bacterial infection of the bovine mammary gland |
WO2004050846A2 (en) * | 2002-12-02 | 2004-06-17 | Biosynexus Incorporated | Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines |
US7335359B2 (en) | 2003-02-06 | 2008-02-26 | Tripep Ab | Glycosylated specificity exchangers |
JP2007516157A (ja) * | 2003-02-06 | 2007-06-21 | トリペップ アクチ ボラゲット | グリコシル化された抗原/抗体又はリガンド/受容体特異性交換体 |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
US7654956B2 (en) | 2004-07-13 | 2010-02-02 | Dexcom, Inc. | Transcutaneous analyte sensor |
US20060134141A1 (en) * | 2004-12-14 | 2006-06-22 | Nabi Biopharmaceuticals | Glycoconjugate vaccines containing peptidoglycan |
EP1850867A1 (en) * | 2005-01-10 | 2007-11-07 | Nabi Biopharmaceuticals | Method of treating staphylococcus aureus infection |
US20060228368A1 (en) * | 2005-04-07 | 2006-10-12 | Nabi Biopharmaceuticals | Method of protecting against staphylococcal infection |
AU2006257774B2 (en) | 2005-06-13 | 2012-03-01 | Glaxosmithkline Biologicals Sa | Use of Panton-Valentine Leukocidin for treating and preventing Staphylococcus infections |
EP2829224B1 (en) † | 2006-02-22 | 2021-03-31 | DexCom, Inc. | Analyte sensor |
US20090053235A1 (en) * | 2006-06-12 | 2009-02-26 | Nabi Biopharmaceuticals | Use of alpha-toxin for treating and preventing staphylococcus infections |
US9119582B2 (en) | 2006-06-30 | 2015-09-01 | Abbott Diabetes Care, Inc. | Integrated analyte sensor and infusion device and methods therefor |
US20090092631A1 (en) * | 2007-03-26 | 2009-04-09 | Tripep Ab | Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response |
WO2009040793A1 (en) * | 2007-09-25 | 2009-04-02 | Check Light Ltd | Compositions and methods for storage of bacterial suspensions |
AU2009246510B2 (en) * | 2008-05-12 | 2014-02-13 | Strox Biopharmaceuticals, Llc | Staphylococcus aureus-specific antibody preparations |
EP3263128A3 (en) | 2009-04-14 | 2018-01-24 | GlaxoSmithKline Biologicals S.A. | Compositions for immunising against staphylococcus aureus |
AU2010352695B2 (en) | 2009-09-30 | 2014-08-21 | Glaxosmithkline Biologicals S.A. | Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides |
EP3199177A1 (en) | 2009-10-30 | 2017-08-02 | GlaxoSmithKline Biologicals S.A. | Purification of staphylococcus aureus type 5 and type 8 capsular saccharides |
GB0919690D0 (en) | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
CN102120761B (zh) * | 2010-12-24 | 2013-02-06 | 新疆维吾尔自治区畜牧科学院兽医研究所 | 一种无荚膜型金黄色葡萄球菌胞外多糖-蛋白质偶联物的制备方法 |
UA105278C2 (ru) | 2012-09-06 | 2014-04-25 | Інститут Біології Клітини Нан України | Способ получения каталитически активных антител (абзимов) с сиалидазной активностью |
AU2015271749B2 (en) | 2014-06-03 | 2018-03-01 | Xbiotech Inc. | Compositions and methods for treating and preventing Staphylococcus aureus infections |
CN105372427A (zh) * | 2015-10-22 | 2016-03-02 | 南昌大学 | 一种基于KMnF4纳米探针的NMR食源性致病菌快速检测方法 |
FR3092292A1 (fr) | 2019-02-06 | 2020-08-07 | Cresco | Système d'éclairage pour un véhicule ou son conducteur. |
CN115105588B (zh) * | 2021-03-23 | 2024-03-15 | 成都威斯克生物医药有限公司 | 一种金黄色葡萄球菌疫苗的生产方法及应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399229A (en) * | 1980-04-14 | 1983-08-16 | Immutron, Inc. | Rapid radioimmunoassay product and method of making and using same |
DE3345864A1 (de) * | 1983-12-19 | 1985-06-27 | Egbert Frh. von 8000 München Malsen-Ponickau | Impfstoff und verfahren zu seiner herstellung |
NZ216119A (en) * | 1985-05-13 | 1989-01-06 | Commw Scient Ind Res Org | Vaccine produced using antigens of a pseudocapsule producing strain of s.aureus |
FR2619122B1 (fr) * | 1987-08-03 | 1990-03-09 | Pasteur Institut | Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede |
US5472846A (en) * | 1994-08-18 | 1995-12-05 | Rotman; M. Boris | Test kit and method for amplification and detection of antigen cells |
US5792617A (en) * | 1994-08-18 | 1998-08-11 | Rotman; M. Boris | Cell proliferation-based amplified detection of analytes |
US5770208A (en) * | 1996-09-11 | 1998-06-23 | Nabi | Staphylococcus aureus B-linked hexosamine antigen |
-
1996
- 1996-09-11 US US08/712,438 patent/US5770208A/en not_active Expired - Lifetime
-
1997
- 1997-09-11 DK DK97941511T patent/DK0925073T3/da active
- 1997-09-11 WO PCT/US1997/016045 patent/WO1998010788A1/en active Application Filing
- 1997-09-11 EP EP97941511A patent/EP0925073B1/en not_active Expired - Lifetime
- 1997-09-11 ES ES97941511T patent/ES2317655T3/es not_active Expired - Lifetime
- 1997-09-11 CA CA2265498A patent/CA2265498C/en not_active Expired - Fee Related
- 1997-09-11 DE DE69739120T patent/DE69739120D1/de not_active Expired - Lifetime
- 1997-09-11 AU AU43405/97A patent/AU725181B2/en not_active Ceased
- 1997-09-11 PT PT97941511T patent/PT925073E/pt unknown
- 1997-09-11 JP JP51383898A patent/JP4282765B2/ja not_active Expired - Fee Related
- 1997-09-11 NZ NZ334828A patent/NZ334828A/xx not_active IP Right Cessation
- 1997-09-11 AT AT97941511T patent/ATE414532T1/de active
-
1998
- 1998-06-22 US US09/102,214 patent/US6194161B1/en not_active Expired - Lifetime
-
2008
- 2008-06-11 JP JP2008152346A patent/JP2009007355A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2265498A1 (en) | 1998-03-19 |
JP4282765B2 (ja) | 2009-06-24 |
AU4340597A (en) | 1998-04-02 |
US5770208A (en) | 1998-06-23 |
JP2001507566A (ja) | 2001-06-12 |
EP0925073B1 (en) | 2008-11-19 |
EP0925073A4 (en) | 2004-12-08 |
US6194161B1 (en) | 2001-02-27 |
AU725181B2 (en) | 2000-10-05 |
EP0925073A1 (en) | 1999-06-30 |
DE69739120D1 (en) | 2009-01-02 |
ATE414532T1 (de) | 2008-12-15 |
WO1998010788A1 (en) | 1998-03-19 |
CA2265498C (en) | 2011-08-02 |
ES2317655T3 (es) | 2009-04-16 |
PT925073E (pt) | 2009-01-22 |
NZ334828A (en) | 2000-10-27 |
JP2009007355A (ja) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE414532T1 (de) | Staphylococcus aureus antigen | |
DK1178824T3 (da) | Staphylococcus aureus-antigenholdig helcellevaccine | |
BR0009157B1 (pt) | Conjugado antígeno transportador compreendendo um antígeno isolado de S. epidermidis, S. haemolyticus ou S. hominis | |
CA2195556A1 (en) | Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype | |
BRPI9912227A (pt) | método para diagnóstico precoce in vitro de carcinomas e de seus estágios iniciais e kit para realização do método. | |
AU583827B2 (en) | Platinum co-ordination compounds | |
CY1111863T1 (el) | Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων | |
DK651387D0 (da) | Roerledningskoeretoej | |
ES2101499T3 (es) | Fibras. | |
BR8805883A (pt) | Acoplamento hidraulico balanceado por pressao com vedacoes metalicas | |
DE3874059T2 (de) | Klappenventile. | |
EP0037110A3 (en) | Method for enzyme immunoassay and peptide-enzyme conjugate, its lyophilizate, antibody and kit therefor | |
DE69021953T2 (de) | Enzymimmuntest für Antigene und dafür verwendbare feste Phase. | |
DE68917777D1 (de) | Enzymatische Waschmittelzusammensetzung. | |
AU7336400A (en) | Diagnostic assay for type 2 heparin-induced thrombocytopenia | |
DE68908896D1 (de) | Flanschkupplung für ventile. | |
DE270451T1 (de) | Leicht zugaengliches klappenventil. | |
DE3485210D1 (de) | Immobilisierte enzymzusammensetzungen. | |
DE3851221T2 (de) | Nichttrennender festphasen-enzymtest. | |
BR9609114A (pt) | Composição inseticida de terra diatomácea | |
FR2506839A1 (fr) | Turboreacteur contra-rotatif simplifie | |
SU1113918A1 (ru) | Антигельминтное средство | |
FI956041A (fi) | Kompositiot ja diagnostiset menetelmät, joissa käytetään monoklonaalisia vasta-aineita CD44V6 vastaan | |
ATE165166T1 (de) | Paracetamolphosphat für immunoassays | |
SE9203159D0 (sv) | Partikel suspension |